These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39118259)

  • 1. The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience.
    Espinoza AF; Montgomery AE; Maamari NC; Dickerson HA; Heczey A; Vasudevan SA; Foster JH
    Pediatr Blood Cancer; 2024 Nov; 71(11):e31214. PubMed ID: 39118259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Outcomes of Neonatal Hepatoblastoma: A Single Center Study.
    Zhou J; Yang L; Fu T; Gao H; Shan Y; Wang J; Zhang L; Xie C; Yin M; Ma J; Pan Q; Xu M; Gu S
    J Pediatr Surg; 2024 Nov; 59(11):161640. PubMed ID: 39174446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
    Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
    Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival analysis of Down syndrome with congenital heart disease: a 5-years registry at QSNICH.
    Layangool T; Sangtawesin C; Kirawittaya T; Prompan W; Prachasilchai P; Pechdamrongsakul A
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S108-14. PubMed ID: 25391181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
    Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome and pattern of failure in hepatoblastoma treated with a consensus protocol in Hong Kong.
    Liu APY; Ip JJK; Leung AWK; Luk CW; Li CH; Ho KKH; Lo R; Chan EKW; Chan ACY; Chung PHY; Chiang AKS
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27482. PubMed ID: 30270490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.
    Qiao GL; Chen Z; Wang C; Ge J; Zhang Z; Li L; Ren J
    J Gastroenterol Hepatol; 2016 Mar; 31(3):621-7. PubMed ID: 26401976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme hepatic resections for the treatment of advanced hepatoblastoma: Are planned close margins an acceptable approach?
    Fonseca A; Gupta A; Shaikh F; Ramphal R; Ng V; McGilvray I; Gerstle JT
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee.
    Trobaugh-Lotrario A; Katzenstein HM; Ranganathan S; Lopez-Terrada D; Krailo MD; Piao J; Chung N; Randazzo J; Malogolowkin MH; Furman WL; McCarville EB; Towbin AJ; Tiao GM; Dunn SP; Langham MR; McGahren ED; Feusner J; Rodriguez-Galindo C; Meyers RL; O'Neill AF; Finegold MJ
    J Clin Oncol; 2022 Feb; 40(5):459-467. PubMed ID: 34874751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct hyperbilirubinemia in infants with congenital heart disease.
    Fujishiro J; Sugiyama M; Ishimaru T; Watanabe M; Sato K; Hoshino N; Uotani C; Kutsukake M; Hirata Y; Oka A
    Pediatr Int; 2018 Feb; 60(2):179-182. PubMed ID: 29178522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts and outcomes for children with hepatoblastoma based on the experience of a tertiary center over the last 21 years.
    Tannuri AC; Cristofani LM; Teixeira RA; Odone Filho V; Tannuri U
    Clinics (Sao Paulo); 2015 Jun; 70(6):387-92. PubMed ID: 26106955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapses in hepatoblastoma patients: clinical characteristics and outcome--experience of the International Childhood Liver Tumour Strategy Group (SIOPEL).
    Semeraro M; Branchereau S; Maibach R; Zsiros J; Casanova M; Brock P; Domerg C; Aronson DC; Zimmermann A; Laithier V; Childs M; Roebuck D; Perilongo G; Czauderna P; Brugieres L
    Eur J Cancer; 2013 Mar; 49(4):915-22. PubMed ID: 23146961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new risk-stratification system for hepatoblastoma in children under six years old and the significance for prognosis evaluation-a 14-year retrospective study from a single center.
    Zhi T; Zhang WL; Zhang Y; Hu HM; Wang YZ; Huang DS
    BMC Cancer; 2021 Apr; 21(1):397. PubMed ID: 33849485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and validation of nomogram prognostic model for predicting survival in hepatoblastoma patients: a population-based study.
    Wang S; Fu S; Li R; Guo Z; Wang Y; Sun W; Sun D
    Updates Surg; 2024 Aug; 76(4):1223-1234. PubMed ID: 38795309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of infants with congenital lobar emphysema and concomitant congenital heart disease.
    Dogan R; Dogan OF; Yilmaz M; Demircin M; Pasaoglu I; Kiper N; Ozcelik U; Boke E
    Heart Surg Forum; 2004; 7(6):E644-9. PubMed ID: 15769700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
    Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical risk factors for patients with ruptured hepatoblastoma in children: a retrospective study from a single center in China.
    Chang S; Yang S; Yang W; Qin H; Cheng H; Chang X; Zhu Z; Yin J; Ren Q; Yu S; Wang H
    Pediatr Surg Int; 2023 Jan; 39(1):76. PubMed ID: 36622431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy.
    Espinoza AF; Patel KR; Shetty PB; Whitlock RS; Sumazin P; Yu X; Sarabia SF; Urbicain M; Heczey A; Masand P; Woodfield SE; López-Terrada DH; Vasudevan SA
    Cancer Med; 2023 Dec; 12(23):21270-21278. PubMed ID: 37962078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes for patients with congenital hepatoblastoma.
    Trobaugh-Lotrario AD; Chaiyachati BH; Meyers RL; Häberle B; Tomlinson GE; Katzenstein HM; Malogolowkin MH; von Schweinitz D; Krailo M; Feusner JH
    Pediatr Blood Cancer; 2013 Nov; 60(11):1817-25. PubMed ID: 23798361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of survival and incidence of hepatoblastoma in the paediatric population.
    Allan BJ; Parikh PP; Diaz S; Perez EA; Neville HL; Sola JE
    HPB (Oxford); 2013 Oct; 15(10):741-6. PubMed ID: 23600968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.